Solid Dosage
GEA offers a complete range of technologies for the high-volume production of solid OTC Painkillers, Analgesics and Fever Relief products
The fast and reliable release of active ingredients is becoming increasingly important, particularly for analgesic drugs. Customer expectations of over-the-counter (OTC) painkillers are “fast and effective” results for immediate relief. At the same time, these dosage forms need to be easy to take and relatively inexpensive.
Beyond rapid action, for example, the benefits of effervescent tablets include an opportunity for formulators to improve the taste of their oral dosage form, a less aggressive delivery method and the consumer appeal associated with taking a fizzy tablet.
Plus, with various market players now developing combination (bilayer) drugs, the need for commercial-scale double-sided rotary tablet presses has never been greater. Designed for the reliable and cost-effective large-scale production of oral solid dosage forms, GEA’s portfolio includes models that combine the benefits of flexibility and robust performance for a wide range of formulations.
Experts in every aspect of high-volume batch processing, GEA offers a complete range of technologies for the production of solid dosage forms: from powder handling to granulating, drying, tablet compression and coating. And, from R&D through scale-up to commercial production, we can identify the most appropriate solution for your specific application and meet your technical requirements.
GEA’s entire range of process equipment is designed with system integration in mind. A modular approach allows customers to select standard process modules to suit their needs. Furthermore, our rotary tablet presses provide a number of options for the high-volume production of large tablets, including continuous manufacturing in low humidity environments.
Affichage de 4 sur 26
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
At GEA, we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product lifecycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
La demande de café connaît une croissance rapide. Découvrez comment la technologie d'extraction continue de GEA booste le rendement, préserve les arômes et économise des ressources.
L'impact du réchauffement climatique est de plus en plus visible dans le monde entier. Les villes de toutes tailles sont confrontées au même défi : fournir à leurs communautés de la chaleur fiable et bon marché, qui soit issue de sources durables. GEA a échangé avec un spécialiste du secteur, Kenneth Hoffmann, Directeur Pompes à chaleur chez GEA Heating & Refrigeration Technologies, pour savoir comment lutter plus rapidement contre le réchauffement de notre planète.
Quelque chose a attiré l'attention de Thomas, éleveur de son état. Au lieu d'effectuer une énième démonstration produit, GEA a présenté ses dernières innovations en utilisant la réalité augmentée (RA). Cette initiative était le point de départ d'un projet de plus grande ampleur : la ferme numérique interactive de GEA.